Advertisement
Screener

VANDA PHARMACEUTICALS INC. (VNDA) ROA

VANDA PHARMACEUTICALS INC. (VNDA) ROA

  • 2026-06-30: ROA -66.64%.
  • 2026-03-31: ROA -55.26%.
  • 2025-12-31: ROA -45.09%.
  • 2025-09-30: ROA -14.01%.

Complete source-backed roa history.

Available history
2010-12-31 to 2026-06-30
Data captured

Historical ROA

DateROA
2026-06-30-66.64%
2026-03-31-55.26%
2025-12-31-45.09%
2025-09-30-14.01%
2025-06-30-10.71%
2025-03-31-7.00%
2024-12-31-2.88%
2024-09-30-2.54%
2024-06-30-1.68%
2024-03-31-0.75%
2023-12-310.39%
2023-09-301.83%
2023-06-302.32%
2023-03-312.48%
2022-12-310.99%
2022-09-301.04%
2022-06-301.80%
2022-03-312.99%
2021-12-315.58%
2021-09-305.91%
2021-06-305.71%
2021-03-315.80%
2020-12-314.37%
2020-09-303.75%
2020-06-3022.47%
2020-03-3123.88%
2019-12-3123.89%
2019-09-3025.65%
2019-06-307.64%
2019-03-316.13%
2018-12-317.59%
2018-09-304.17%
2018-06-300.43%
2018-03-31-1.53%
2017-12-31-7.58%
2017-09-30-6.97%
2017-06-30-4.85%
2017-03-31-6.50%
2016-12-31-8.56%
2016-09-30-15.45%
2016-06-30-20.41%
2016-03-31-20.32%
2015-12-31-18.71%
2015-09-3020.25%
2015-06-3023.55%
2015-03-3117.08%
2014-12-3111.76%
2014-09-30-72.35%
2014-06-30-71.09%
2014-03-31-35.60%
2013-12-31-14.69%
2013-09-30-13.30%
2013-06-30-17.57%
2013-03-31-20.12%
2012-12-31-21.13%
2012-09-30-17.90%
2012-06-30-15.27%
2012-03-31-10.37%
2011-12-31-5.37%
2011-09-30-1.06%
2011-06-302.05%

Annual ROA

DateROA
2025-12-31-45.09%
2024-12-31-2.88%
2023-12-310.39%
2022-12-310.99%
2021-12-315.58%
2020-12-314.37%
2019-12-3123.89%
2018-12-317.59%
2017-12-31-7.58%
2016-12-31-8.56%
2015-12-31-18.71%
2014-12-3111.76%
2013-12-31-14.69%
2012-12-31-21.13%
2011-12-31-5.37%
2010-12-313.37%

Similar stocks

Stock NameCountryMarket CapPE Ratio
STANDARD BIOTOOLS INC. (LAB)United States$0.297B3.80
ROCKET PHARMACEUTICALS, INC. (RCKT)United States$0.296B-21.78
GT Biopharma, Inc. (GTBP)United States$0.309B-4.58
ABEONA THERAPEUTICS INC. (ABEO)United States$0.312B-5.63
Fulcrum Therapeutics, Inc. (FULC)United States$0.289B-3.28
Contineum Therapeutics, Inc. (CTNM)United States$0.289B-4.40
Prelude Therapeutics Inc (PRLD)United States$0.318B-7.01
Perspective Therapeutics, Inc. (CATX)United States$0.284B-3.34
Evommune, Inc. (EVMN)United States$0.320B-5.10
Upstream Bio, Inc. (UPB)United States$0.284B-2.42